Senescent macrophages alter fibroblast fibrogenesis in response to SARS-CoV-2 infection
Author:
Pence Brandt1, Zhang Yufeng1, Antwi Ivy2, Cory Theodore James2ORCID
Affiliation:
1. University of Memphis College of Health Sciences , Memphis , TN , USA 2. Department of Clinical Pharmacy and Translational Science , University of Tennessee Health Science Center College of Pharmacy , Memphis , TN , USA
Abstract
Abstract
SARS-CoV-2 has, since its emergence in 2019, become a global pandemic. Disease outcomes are worsened in older patients who are infected. The causes for this is multifactorial, but one potential cause for this disparity is increased rates of cellular senescence in older individuals, particularly in immune cells. Cellular senescence, the accumulation of factors resulting in cell growth arrest and apoptosis resistance, increases as individuals age. In immune cells, senescence is associated with increased inflammation, and alterations in immune response. We utilized a co-culture system consisting of senescent or non-senescent macrophages directly cultured with fibroblasts, and infected with SARS-CoV-2. We assessed the expression of collagen and fibronectin, important molecules in the extracellular matrix, as well as a number of fibrogenic factors. We observed that infection with SARS-CoV-2 induced collagen production in co-cultures with senescent, but not non-senescent macrophages. Fibronectin expression was decreased in both co-culture conditions. While significant results were not observed, concentrations of other fibrogenic molecules were consistent with the collagen results. These data demonstrate that senescence in macrophages alters the production of fibrotic molecules from fibroblasts in a SARS-CoV-2 infection model. As collagen and fibronectin expression are generally directly correlated, this suggests that senescence dysregulates fibrogenesis in response to infection with SARS-CoV-2. There is a need to further investigate the mechanisms for these changes.
Funder
National Institute on Drug Abuse UTHSC/University of Memphis SARS-CoV-2/COVID-19 Research CORNET
Publisher
Walter de Gruyter GmbH
Reference49 articles.
1. Centers for Disease Control and Prevention. 2022. COVID data tracker. Available from: https://covid.cdc.gov/covid-data-tracker/#trends_dailydeaths. 2. Zhou, P, Yang, XL, Wang, XG, Hu, B, Zhang, L, Zhang, W, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270–3. https://doi.org/10.1038/s41586-020-2012-7. 3. Guan, WJ, Ni, ZY, Hu, Y, Liang, WH, Ou, CQ, He, JX, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20. https://doi.org/10.1056/nejmoa2002032. 4. Yanez, ND, Weiss, NS, Romand, JA, Treggiari, MM. COVID-19 mortality risk for older men and women. BMC Publ Health 2020;20:1–7. https://doi.org/10.1186/s12889-020-09826-8. 5. Bernal, JL, Andrews, N, Gower, C, Robertson, C, Stowe, J, Tessier, E, et al.. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ 2021;373. https://doi.org/10.1136/bmj.n1088.
|
|